BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6287489)

  • 1. The effects of various tryptolines (tetrahydro-beta-carbolines) on 5-hydroxytryptamine receptors.
    Holman RB
    Prog Clin Biol Res; 1982; 90():167-81. PubMed ID: 6287489
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of tryptolines (1, 2, 3, 4-tetrahydro-beta-carbolines) on monoamine metabolism and the platelet aggregation response in human platelets.
    Youdim MB; Oppenheim B
    Neuroscience; 1981; 6(4):801-10. PubMed ID: 7242917
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of two distinctive beta-carbolines on serotonin binding in human platelets.
    Taylor DL; Tansey W; Cook JM; Ho BT
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):133-6. PubMed ID: 3983465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of tetrahydro-beta-carbolines with brain serotonin metabolism.
    Buckholtz NS
    Prog Clin Biol Res; 1982; 90():183-90. PubMed ID: 7111318
    [No Abstract]   [Full Text] [Related]  

  • 5. Tryptamine binding sites: potential site of action of tetrahydro-beta-carbolines.
    Kellar KJ; Cascio CS
    Prog Clin Biol Res; 1982; 90():209-12. PubMed ID: 7111320
    [No Abstract]   [Full Text] [Related]  

  • 6. Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.
    Audia JE; Evrard DA; Murdoch GR; Droste JJ; Nissen JS; Schenck KW; Fludzinski P; Lucaites VL; Nelson DL; Cohen ML
    J Med Chem; 1996 Jul; 39(14):2773-80. PubMed ID: 8709108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates.
    Keller KJ; Elliott GR; Holman RB; Vernikos-Danellis J; Barchas JD
    J Pharmacol Exp Ther; 1976 Sep; 198(3):619-25. PubMed ID: 978463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B; Hefez A; Youdim MB
    Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel 5,8-disubstituted-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indoles as 5-HT(6) and H(1) receptors antagonists.
    Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Tkachenko SE
    Arch Pharm (Weinheim); 2009 Dec; 342(12):740-7. PubMed ID: 19921682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of platelet aggregation by 1,2,3,4-tetrahydro-beta-carbolines: evidence for 5-hydroxytryptamine antagonistic activities (author's transl)].
    Rehse K; Siemann U
    Arch Pharm (Weinheim); 1981 Jul; 314(7):627-30. PubMed ID: 7294977
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of stress, beta-carbolines, diazepam, and Ro 15-1788 on GABA receptors in the rat brain.
    Biggio G
    Adv Biochem Psychopharmacol; 1983; 38():105-19. PubMed ID: 6322535
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines.
    Bojarski AJ; Cegła MT; Charakchieva-Minol S; Mokrosz MJ; Maćkowiak M; Misztal S; Mokrosz JL
    Pharmazie; 1993 Apr; 48(4):289-94. PubMed ID: 8321880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aggregation and 3H-serotonin release from thrombocytes stimulated by serotonin in patients with migraine].
    Pukhal'skaia TG; Kolosova OA; Men'shikov MIu
    Biull Eksp Biol Med; 1998 Aug; 126(8):156-9. PubMed ID: 9777225
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.
    Khorana N; Smith C; Herrick-Davis K; Purohit A; Teitler M; Grella B; Dukat M; Glennon RA
    J Med Chem; 2003 Aug; 46(18):3930-7. PubMed ID: 12930153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beta-carbolines of plasma corticosterone in mice.
    Meyer JS; Buckholtz NS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):205-13. PubMed ID: 1085012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of tetrahydronorharmane (tetrahydro-beta-carboline) on 5-hydroxytryptamine and dopamine mediated mechanisms.
    Pannier L; Rommelspacher H
    Neuropharmacology; 1981 Jan; 20(1):1-8. PubMed ID: 7194427
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin receptor interactions of harmaline and several related beta-carbolines.
    Glennon RA
    Life Sci; 1981 Aug; 29(8):861-5. PubMed ID: 7300579
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
    Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indoles. 9. 4-Arylated tetrahydro-beta-carbolines--synthesis and first pharmacologic data].
    Lehmann J; Jiang N; Behncke A
    Arch Pharm (Weinheim); 1993 Oct; 326(10):813-8. PubMed ID: 8267516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.